Global Antibiotics Market 2014-2018

2014-09-17
Price :
Published : Sep-2014
No. of Pages : 96

Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term “antibiotic” is often used synonymously with antibacterial; however, the term “antibiotic” was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. It can be bacteriostatic or bactericidal in nature. Antibiotics are medicines that are used to treat infections caused by bacteria (e.g., respiratory tract infections). Antibiotics work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).

TechNavio’s analysts forecast the Global Antibiotics market to grow at a CAGR of 1.41 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Antibiotics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various antibiotics for human use. The Global Antibiotics market can be divided into eight segments: Beta-lactams, Macrolides, Aminoglycosides, Phenicols, Quinolones, Sulfonamides, Tetracyclines, and Others.

TechNavio’s report, the Global Antibiotics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Antibiotics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • Bayer HealthCare
  • Bristol Myers Squibb
  • Cubist Pharmaceuticals
  • Daiichi Sankyo
  • F. Hoffmann-La Roche
  • Takeda Pharmaceutical

Market Driver

  • Increased Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • Emergence of Drug-resistant Strains
  • For a full, detailed list, view our report

Market Trend

  • Increase in Demand for Antibiotics
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017" provides an overview of Corrosive Esophagitis (Erosive Esophagitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Corrosive Esophagitis (Erosive Esophagitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Cli......
$2500

Cyst Global Clinical Trials Review, H2, 2017

Cyst Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cyst Global Clinical Trials Review, H2, 2017" provides an overview of Cyst clinical trials scenario. This report provides top line data relating to the clinical trials on Cyst. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ di......
$2500

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Critical Limb Ischemia Global Clinical Trials Review, H2, 2017" provides an overview of Critical Limb Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Critical Limb Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma e......
$2500

Cystic Fibrosis Global Clinical Trials Review, H2, 2017

Cystic Fibrosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cystic Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Cystic Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystic Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials databa......
$2500

Contact Dermatitis Global Clinical Trials Review, H2, 2017

Contact Dermatitis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Contact Dermatitis Global Clinical Trials Review, H2, 2017" provides an overview of Contact Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Contact Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017

Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top line data relating to the clinical trials on Crohn's Disease (Regional Enteritis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are gene......
$2500

Cystinosis Global Clinical Trials Review, H2, 2017

Cystinosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cystinosis Global Clinical Trials Review, H2, 2017" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2017

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2017" provides an overview of Contrast Induced Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Contrast Induced Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500

Croup Global Clinical Trials Review, H2, 2017

Croup Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Croup Global Clinical Trials Review, H2, 2017" provides an overview of Croup clinical trials scenario. This report provides top line data relating to the clinical trials on Croup. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80......
$2500

Cystitis Global Clinical Trials Review, H2, 2017

Cystitis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cystitis Global Clinical Trials Review, H2, 2017" provides an overview of Cystitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500